EP1502576A3 - Composition contentant un 2-thioacétamide, son utilisation pour stimuler la pousse des fibres kératiniques et/ou freiner leur chute - Google Patents

Composition contentant un 2-thioacétamide, son utilisation pour stimuler la pousse des fibres kératiniques et/ou freiner leur chute Download PDF

Info

Publication number
EP1502576A3
EP1502576A3 EP04291767A EP04291767A EP1502576A3 EP 1502576 A3 EP1502576 A3 EP 1502576A3 EP 04291767 A EP04291767 A EP 04291767A EP 04291767 A EP04291767 A EP 04291767A EP 1502576 A3 EP1502576 A3 EP 1502576A3
Authority
EP
European Patent Office
Prior art keywords
cycle
éventuellement
moins
pyridine
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04291767A
Other languages
German (de)
English (en)
Other versions
EP1502576A2 (fr
Inventor
Roger Rozot
Christophe Boulle
Phillipe Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of EP1502576A2 publication Critical patent/EP1502576A2/fr
Publication of EP1502576A3 publication Critical patent/EP1502576A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention se rapporte à une composition de soin ou de maquillage des cheveux ou des cils, destinée notamment à améliorer leur aspect et/ou augmenter leur densité, contenant une quantité efficace d'un composé 2-thioacétamide de formule (1) ou d'un de ses sels :
Figure 80000001
   dans laquelle :
  • a) R1 et R2 représentent indépendamment :
  • un atome d'hydrogène ; un radical alkyle en C1-C20 éventuellement substitué par au moins un substituant ; un cycle hydrocarboné C1, éventuellement accolé à un cycle C2 contenant éventuellement au moins un hétéroatome, ces et cycles C1 et C2 pouvant comporter au moins une fonction carbonyle ou thiocarbonyle et être substitués ; un hétérocycle Hy2 éventuellement accolé à un cycle C2 contenant éventuellement au moins un hétéroatome pour former un hétérocycle Hy3, ces cycles Hy2 et C2 pouvant être substitués et/ou comporter au moins une fonction carbonyle ou thiocarbonyle ; ou un groupe C(=NR)R', C(=NR)NR'R", COR, CSR, COOR, CONRR', SO2R ou SO2NRR' ;
  • b) R3 représente :
  • un radical alkyle en C1-C20 éventuellement substitué par au moins un substituant ; un cycle hydrocarboné C3, éventuellement accolé à un cycle C4 contenant éventuellement au moins un hétéroatome, ces cycles C3 et C4 pouvant être substitués et/ou comporter au moins une fonction carbonyle ou thiocarbonyle ; un hétérocycle Hy4 représentant un cycle pyrrole, furanne, thiophène ou pyrazole, éventuellement accolé à un cycle C5 représentant un cycle phényle, pyridine ou pyrimidine, ces cycles Hy4 et C5 pouvant être substitués ; un cycle pyridine éventuellement accolé à un cycle C2 contenant éventuellement au moins un hétéroatome, ces cycles pyridine et C2 pouvant être substitués et/ou comporter au moins une fonction carbonyle ou thiocarbonyle ; un hétérocycle Hy5 différent de Hy4 et du cycle pyridine, éventuellement accolé à un cycle C2 contenant éventuellement au moins un hétéroatome, ces cycles Hy5 et C2 pouvant être substitués et/ou comporter au moins une fonction carbonyle ou thiocarbonyle ; ou un groupe C(=NR)R', C(=NR)NR'R", COR, CSR, COOR ou CONRR'.
    •
    EP04291767A 2003-07-31 2004-07-12 Composition contentant un 2-thioacétamide, son utilisation pour stimuler la pousse des fibres kératiniques et/ou freiner leur chute Withdrawn EP1502576A3 (fr)

    Applications Claiming Priority (2)

    Application Number Priority Date Filing Date Title
    FR0309476A FR2858216B1 (fr) 2003-07-31 2003-07-31 Composition contenant un 2-thioacetamide, son utilisation pour stimuler la pousse des fibres keratiniques et/ou freiner leur chute
    FR0309476 2003-07-31

    Publications (2)

    Publication Number Publication Date
    EP1502576A2 EP1502576A2 (fr) 2005-02-02
    EP1502576A3 true EP1502576A3 (fr) 2005-06-22

    Family

    ID=33523042

    Family Applications (1)

    Application Number Title Priority Date Filing Date
    EP04291767A Withdrawn EP1502576A3 (fr) 2003-07-31 2004-07-12 Composition contentant un 2-thioacétamide, son utilisation pour stimuler la pousse des fibres kératiniques et/ou freiner leur chute

    Country Status (3)

    Country Link
    EP (1) EP1502576A3 (fr)
    JP (1) JP2005060391A (fr)
    FR (1) FR2858216B1 (fr)

    Families Citing this family (5)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    US8741537B2 (en) 2005-03-04 2014-06-03 Fujifilm Corporation Positive resist composition and pattern-forming method using the same
    US9365610B2 (en) 2013-11-18 2016-06-14 Arcturus Therapeutics, Inc. Asymmetric ionizable cationic lipid for RNA delivery
    AU2014348212C1 (en) 2013-11-18 2018-11-29 Arcturus Therapeutics, Inc. Ionizable cationic lipid for RNA delivery
    US10526284B2 (en) 2016-12-21 2020-01-07 Arcturus Therapeutics, Inc. Ionizable cationic lipid for RNA delivery
    US10383952B2 (en) 2016-12-21 2019-08-20 Arcturus Therapeutics, Inc. Ionizable cationic lipid for RNA delivery

    Citations (7)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    FR1204564A (fr) * 1958-04-17 1960-01-27 Oreal Nouveau procédé d'ondulation permanente des cheveux
    JPH0543530A (ja) * 1991-08-10 1993-02-23 Taisho Pharmaceut Co Ltd アルカンアミドカルボキシベタイン
    US5409917A (en) * 1991-03-05 1995-04-25 Marvin S. Towsend Topical treatment of acne with cephalosporins
    US5639741A (en) * 1992-05-20 1997-06-17 Merck & Co., Inc. 17-amino substituted 4-azasteroid 5α-reductase inhibitors
    WO2003014073A1 (fr) * 2001-08-09 2003-02-20 Genfit Composes derives d'acides gras preparation et utilisations
    KR20030088742A (ko) * 2002-05-14 2003-11-20 주식회사 비봉파인 시스테인 및 그 유도체 또는 에르도스테인을 함유하는미백용 조성물
    WO2004073593A2 (fr) * 2003-02-12 2004-09-02 Genfit Aminopropanediols acyles et de leurs analogues azotes et sulfures pour diverses applications therapeutiques

    Family Cites Families (1)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    AUPR379801A0 (en) * 2001-03-19 2001-04-12 Unisearch Limited Use of a substantially cell membrane impermeable compound for treating arthritis

    Patent Citations (7)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    FR1204564A (fr) * 1958-04-17 1960-01-27 Oreal Nouveau procédé d'ondulation permanente des cheveux
    US5409917A (en) * 1991-03-05 1995-04-25 Marvin S. Towsend Topical treatment of acne with cephalosporins
    JPH0543530A (ja) * 1991-08-10 1993-02-23 Taisho Pharmaceut Co Ltd アルカンアミドカルボキシベタイン
    US5639741A (en) * 1992-05-20 1997-06-17 Merck & Co., Inc. 17-amino substituted 4-azasteroid 5α-reductase inhibitors
    WO2003014073A1 (fr) * 2001-08-09 2003-02-20 Genfit Composes derives d'acides gras preparation et utilisations
    KR20030088742A (ko) * 2002-05-14 2003-11-20 주식회사 비봉파인 시스테인 및 그 유도체 또는 에르도스테인을 함유하는미백용 조성물
    WO2004073593A2 (fr) * 2003-02-12 2004-09-02 Genfit Aminopropanediols acyles et de leurs analogues azotes et sulfures pour diverses applications therapeutiques

    Non-Patent Citations (2)

    * Cited by examiner, † Cited by third party
    Title
    DATABASE CA CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002325481, retrieved from STN Database accession no. 142: 225 230 *
    DATABASE CHEMABS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002288744, retrieved from STN Database accession no. 119: 55 699 *

    Also Published As

    Publication number Publication date
    EP1502576A2 (fr) 2005-02-02
    FR2858216A1 (fr) 2005-02-04
    JP2005060391A (ja) 2005-03-10
    FR2858216B1 (fr) 2008-04-04

    Similar Documents

    Publication Publication Date Title
    MA26996A1 (fr) Derives de glutaramide a substituant n-phenpropylcyclopentyle, servant d'inhibiteurs de nep pour un trouble d'eveil sexuel feminin
    MEP12508A (en) Derivatives of n-/phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics
    MA26879A1 (fr) Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation.
    CA2662848C (fr) Derives de 2-aryl-6-phenyl-imidazo[1,2-.alpha.]pyridines, leur preparation et leur application en therapeutique
    CA2400141A1 (fr) Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
    MA26991A1 (fr) Triazolopyridines servant d'agents anti-inflammatoires
    WO2003039451A3 (fr) Derive de thiazole et utilisation pharmaceutique
    MA28438B1 (fr) Derives azabicyclo (3.1.0) hexane utiles comme modulateurs des recepteurs d3 de la dopamine
    BRPI0707185B1 (pt) Compostos de Imidazóis substituídos, composição farmacêutica, veterinária ou agrícola compreendendo ditos compostos e uso dos mesmos para o tratamento de infestação parasítica
    EA200500006A1 (ru) Лекарственное средство для лечения нейродегенеративных заболеваний
    FR2398493A1 (fr) Nouveaux derives 2,4-hexadieniques, leur preparation et leur application en tant qu'agents cosmetiques
    ATE173256T1 (de) Azolidindion-derivate und ihre anwendung als antihyperglykämika
    WO2004028441A3 (fr) Compose heterocyclique pour stimuler ou induire la pousse des cheveux ou des cils et/ou freiner leur chute, composition le contenant, ses utilisations
    RU2394031C2 (ru) Соли четвертичного аммония в качестве антагонистов м3
    FR2426694A1 (fr) Cephalosporines perfectionnees, leur procede de preparation et leur application therapeutique
    EP1502576A3 (fr) Composition contentant un 2-thioacétamide, son utilisation pour stimuler la pousse des fibres kératiniques et/ou freiner leur chute
    EP1157998A4 (fr) Composes heterocycliques, leurs intermediaires, et inhibiteurs d'elastase
    MA32978B1 (fr) Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique
    MA29961B1 (fr) Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
    NZ334701A (en) Dihydropyrones and use in treating retrovirus infections and diseases
    KR930012698A (ko) β-옥소-β-벤젠프로판티오아미드 유도체
    FR2854634A1 (fr) Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
    FR2428436A1 (fr) Nouvelles compositions cosmetiques pour le traitement de l'etat gras des cheveux et de la peau, composes nouveaux et leur procede de preparation
    DE69117879D1 (de) Arzneimittel für die Verhütung und Behandlung von Krankheiten der Kreislauforgane enthaltend Spiro-3-heteroazolidin-Verbindungen
    US2886488A (en) Method of treating topical skin disorders with benzoxathiol compositions

    Legal Events

    Date Code Title Description
    PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

    Free format text: ORIGINAL CODE: 0009012

    AK Designated contracting states

    Kind code of ref document: A2

    Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

    AX Request for extension of the european patent

    Extension state: AL HR LT LV MK

    PUAL Search report despatched

    Free format text: ORIGINAL CODE: 0009013

    RIC1 Information provided on ipc code assigned before grant

    Ipc: 7A 61P 17/14 B

    Ipc: 7A 61K 7/06 A

    AK Designated contracting states

    Kind code of ref document: A3

    Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

    AX Request for extension of the european patent

    Extension state: AL HR LT LV MK

    17P Request for examination filed

    Effective date: 20051222

    AKX Designation fees paid

    Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

    17Q First examination report despatched

    Effective date: 20061229

    STAA Information on the status of an ep patent application or granted ep patent

    Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

    18D Application deemed to be withdrawn

    Effective date: 20090617